micro-community-banner
  • Saved

4yr
Share secrets for success for students with ADD/ADHD

Share secrets for success for students with ADD/ADHD

Source : https://onlinelibrary.wiley.com/doi/abs/10.1002/dhe.31199

Students with attention deficit hyperactivity disorder should not treat their ADHD lightly, said Shanna Pearson, Founder and President of Expert ADHD Coaching. These students have double the college drop-out rate...


Abstract: Students with attention deficit hyperactivity disorder should not treat their ADHD lightly, said Shanna Pearson, Founder and President of Expert ADHD Coaching. These students have double the college drop-out rate as students without ADHD, she added. But ADHD can be a superpower if used correctly. “Your brain will never run out of...

  • Saved

4yr

Agmatine improves olfactory and cognitive deficits in Spontaneously Hypertensive Rats (SHR): An animal model of Attention Deficit Hyperactivity Disorder (ADHD).

Source : https://psycnet.apa.org/doi/10.1037/bne0000499



This study provides the first evidence that agmatine improves olfactory and cognitive impairments observed in an animal model of ADHD. (PsycInfo Database Record (c) 2021 APA, all rights reserved)





  • Saved

4yr

The effects of EEG neurofeedback on attention and sleep in individuals with and without ADHD or insomnia: a literature review - ggz.nl

Source : https://ggz.nl/publication/the-effects-of-neurofeedback-on-attention-and-sleep-in-individuals-with-and-without-adhd-or-insomnia-a-literature-review/

The reviewed literature provides evidence that standard E-NFT protocols may have a positive long-lasting effect on the inattention and hyperactivity/impulsivity symptoms in children with ADHD. In healthy children and young...



Therefore, this review examines the efficacy of E-NFT on attention and sleep in patients and healthy individuals. The reviewed literature provides evidence that standard E-NFT protocols may have a positive long-lasting effect on the inattention and hyperactivity/impulsivity symptoms in children with ADHD.

  • Saved

4yr
Feigned ADHD Associated Cognitive Impairment: Utility of Integrating an Eye-trAcker and the MOXO-dCPT - Astar Lev, Tomer Elbaum, Corinne Berger, Yoram Braw, 2021

Feigned ADHD Associated Cognitive Impairment: Utility of Integrating an Eye-trAcker and the MOXO-dCPT - Astar Lev, Tomer Elbaum, Corinne Berger, Yoram Braw, 2021

Source : https://doi.org/10.1177/10870547211063643

The current study assessed the utility of eye-movements measures, gathered while participants performed a commercially available Continuous Performance Test (CPT), to detect feigned ADHD-associated cognitive impairment. Healthy simulators ( n = 37),...



Results: "Simulators gazed significantly longer at regions that were irrelevant for successful MOXO-dCPT performance compared to ADHD patients and healthy controls. This eye-movement measure, however, had lower sensitivity than traditional MOXO-dCPT indices."

  • Saved

4yr
Optimizing ADHD Therapy

Most children are returning to onsite learning this year. While this is good news, it can bring back challenges to children diagnosed with attention deficit hyperactivity disorder (ADHD), their families, and their teachers.



One challenge of treating ADHD continues to be the onset and duration of action of the ADHD medications. According to the CDC, stimulants are the best known and most widely available treatments for ADHD with 70-80% of the children treated with them showing fewer symptoms. Short and long-acting stimulants are available with the treatment goal being to find the most efficacious drug that also causes the least bothersome side effects. Short-acting drugs are released immediately and last about 4 hours, while long-acting drugs are released over time and last up to 14 hours.



Although both types of stimulants reduce the symptoms of ADHD, they may start or wear off at inopportune times. For example, if a child receives a short-acting drug in the morning before school, its effect will likely disappear by the afternoon while they are still in school. Similarly, a child can be given a long-acting drug in the morning. This drug has the disadvantage of not kicking in until the child arrives at school, leaving breakfast and the morning routine chaotic, and still dealing with it wearing off around homework or bedtime. These problems can be stressful for the child, parents, and teachers as neither provides optimal coverage throughout the child’s waking hours.



How do you optimize onset and duration of action? What percent of your ADHD patients are prescribed both short-acting (immediate release, IR) and long-acting (extended release, ER) therapies?



CDC: Treatment of ADHD. Source, accessed September 10, 2021.

CHADD, “Peaks and Troughs: Uneven Medications & ADHD”, Attention Magazine Fall 2017 (source)

 

  • 4yr
    The choice and optimal treatment will depend on how long parents want the meds to work , when is the most difficult time for the child , and whether child Show More
  • 4yr
    I like the approach of a long acting stimulant in the morning and adding a short acting in the late afternoon to facilitate children getting their homework done and still Show More

Show More Comments